期刊文献+

ELISA法研究重组水蛭素在比格犬体内的药动学 被引量:1

Determination and study of r-hirudin in beagle dog′s plasma by ELISA and its pharmacokinetics
下载PDF
导出
摘要 目的建立一种酶联免疫吸附试验(ELISA)方法 ,测定比格犬血液中重组水蛭素浓度,进而研究其药动学特点。方法选取合格比格犬6只,静脉注射重组水蛭素0.2 mg/kg,于给药后2、5、10、20、40、60、120、240和480 min取血2 mL,分离血清,用ELISA检测其血药浓度。结果静脉注射重组水蛭素的T1/2α(0.37±0.029)h,T1/2β(2.64±0.92)h;ATU0-T(372.98±27.87)ng/(mL.h)。结论经ELISA测定血中的药物浓度,药时曲线经3P97拟合,表明静脉注射重组水蛭素在动物体内为二室模型。 Objective To develop a ELISA method for determining r-hirudin(rH) in Beagle dog's plasma so as to provide a methodology for the study of its harmacokineties. Methods 6 eligible beagle clogs were intravenously injected with rH(0.2mg/kg). The method of ELISA was used to detect the rH in Beagle dog's plasma after iv administration 2,5,10,20,40,60,120,240 and 480 min. Results The pharmacokinetie parameters determined by ELISA method were as follows:T1/2a were (0.37±0. 029)h,T1/2βwere (2.64±0.92)h,ATU0-T were (372.98±27.87)ng/ (mE ·h). Conclusion The result showed that drug concentration-time curve was conformed to two compartment open models.
出处 《检验医学与临床》 CAS 2010年第10期941-943,945,共4页 Laboratory Medicine and Clinic
关键词 重组水蛭素 酶联免疫吸附试验 药动学 r-Hirudin ELISA, pharmacokinetics
  • 相关文献

参考文献7

二级参考文献15

  • 1丁有学,张翊,郭莹,韩春梅,刘兰,饶春明,王军志.重组水蛭素生物学活性检测参考品的制备和标定[J].中国生物制品学杂志,2005,18(6):498-500. 被引量:3
  • 2傅中平,周吉燕,王富军.苦瓜中胰蛋白酶抑制剂活性的测定方法研究[J].食品与药品,2007,9(04A):14-17. 被引量:6
  • 3MoW SongHY.Research advance on clinical application of recombinant hirudin [J].国外医学:药学分册,2004,31(2):82-86. 被引量:1
  • 4Iyer L. Koza M, Iqbal O, et al. Studies on the pharmacokinetics and pharmacyodynamics of recombinant hirudin (rHV2-1ys47) after intravenous and subcutaneous administration in dogs [J]. Tkromb Res, 1993, 69: 256-269. 被引量:1
  • 5Meiring S M, Lotter M G, Badenhorst P N, et al. Sites of elimination and pharmacokinetics of recombinant [1311] lepirudin in baboons [J]. J Pharm Sci, 1999, 88(5): 523-529. 被引量:1
  • 6LiuXW SongHF TangZM etal.Pharmacokinetics and partial thromboplastin time after intravenous recombinant hirudin variant—2 in rhesus monkeys[J].药学学报,2002,23(9):842-846. 被引量:1
  • 7JiangSY LiGX HanGZ.Study on pharmacokinetics of novel recombinant hirudin by ELISA in rats[J].中国药学杂志,2002,37(7):556-557. 被引量:1
  • 8Liu C X, Wei G L, Li Q S. Methodology study of validation for bioanalysis in study on pharmacokinetics and bioavailability [J]. Asian J Drug Metab Pharmacokinet, 2001, 1 (4):279-286. 被引量:1
  • 9Xia J H. Validation of analytical methods for pharmacokineties, bioavailability, and bioeqaivalence studies [J]. Asian J Drug Metab Pharmacokinet, 2001, l(2): 95-100. 被引量:1
  • 10Lalitha L, Jawed F. Determination of specific activity of recombinant hirudin using a thrombin titration method [ J ]. Thromb Res, 1995,78 (3) :259-263. 被引量:1

共引文献13

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部